Panaxium is developing an ultra-precision personalized neurostimulation therapy for stroke patients. The therapy combines AI-enabled MRI imaging analysis with implants to drive bioelectrically-instigated brain rewiring to restore lost functions (motor, speech, cognitive, etc.). Uniquely, the implants are biocompatible and iontronic, using ion-conducting polymers. Panaxium can measure and stimulate the necessary neural targets on a continuous and long-term basis with high resolution (both spatial and temporal), precision, sensitivity, and safety.